US Bancorp’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1K | Sell |
592
-64
| -10% | -$1.09K | ﹤0.01% | 3413 |
|
|
2025
Q1 | $12.8K | Buy |
656
+348
| +113% | +$6.8K | ﹤0.01% | 3339 |
|
|
2024
Q4 | $7.64K | Sell |
308
-276
| -47% | -$6.84K | ﹤0.01% | 3509 |
|
|
2024
Q3 | $14.3K | Sell |
584
-1,651
| -74% | -$40.5K | ﹤0.01% | 3229 |
|
|
2024
Q2 | $52.4K | Sell |
2,235
-9
| -0.4% | -$211 | ﹤0.01% | 2650 |
|
|
2024
Q1 | $74.1K | Buy |
2,244
+227
| +11% | +$7.5K | ﹤0.01% | 2496 |
|
|
2023
Q4 | $54.9K | Sell |
2,017
-7
| -0.3% | -$191 | ﹤0.01% | 2625 |
|
|
2023
Q3 | $48.7K | Buy |
2,024
+1,707
| +538% | +$41.1K | ﹤0.01% | 2450 |
|
|
2023
Q2 | $10.1K | Sell |
317
-294
| -48% | -$9.39K | ﹤0.01% | 3229 |
|
|
2023
Q1 | $18.7K | Buy |
611
+189
| +45% | +$5.79K | ﹤0.01% | 3017 |
|
|
2022
Q4 | $16.5K | Sell |
422
-6,287
| -94% | -$246K | ﹤0.01% | 3076 |
|
|
2022
Q3 | $319K | Sell |
6,709
-539
| -7% | -$25.6K | ﹤0.01% | 1604 |
|
|
2022
Q2 | $282K | Sell |
7,248
-3,554
| -33% | -$138K | ﹤0.01% | 1725 |
|
|
2022
Q1 | $619K | Buy |
10,802
+571
| +6% | +$32.7K | ﹤0.01% | 1432 |
|
|
2021
Q4 | $815K | Buy |
10,231
+600
| +6% | +$47.8K | ﹤0.01% | 1293 |
|
|
2021
Q3 | $839K | Buy |
9,631
+153
| +2% | +$13.3K | ﹤0.01% | 1269 |
|
|
2021
Q2 | $1.22M | Buy |
9,478
+4,441
| +88% | +$571K | ﹤0.01% | 1106 |
|
|
2021
Q1 | $403K | Buy |
5,037
+4,037
| +404% | +$323K | ﹤0.01% | 1606 |
|
|
2020
Q4 | $82K | Sell |
1,000
-2,000
| -67% | -$164K | ﹤0.01% | 2300 |
|
|
2020
Q3 | $74K | Buy |
+3,000
| New | +$74K | ﹤0.01% | 2210 |
|